Imagine you’re a woman who’s expecting.

You know the chances that you have HIV are extremely low, but you consent to being screened for the virus because the CDC recommends it for pregnant people.

Then your world implodes. The test comes back positive, and the doctor tells you the baby you’re carrying could have HIV, too. So you panic, and you can’t stop wondering, how?

In a hotel named for Paul Revere, whose daring midnight ride through the Boston countryside warned that the British were coming, the University of Pittsburgh declared that it is poised to lead revolutionary change in drug discovery and health care delivery.

“Over the next five years, we will transform the way medical research is done. We will transform the way drug discovery is done. And we definitely want to transform the way new products are done,” said Anantha Shekhar, senior vice chancellor for the health sciences and John and Gertrude Petersen Dean, School of Medicine.

The University of Pittsburgh and the technology company Leidos announced a $10 million partnership to advance Pitt’s Computational Pathology and AI Center of Excellence (CPACE) on Friday, April 18, 2025.

The first focus of the five-year collaboration will be developing AI-powered tools for quicker detection of diseases, like heart disease and cancer, reducing diagnostic turnaround times and enabling earlier, more effective care management.

In a remarkable achievement, School of Computing and Information (SCI) Assistant Professor Longfei Shangguan and his interdisciplinary research team received the prestigious Best Paper Award at MobiCom 2024, the top international conference on mobile computing and networking.

It used to be that if you wanted to track down a rare frog, you’d have to go to a likely place and wait until you heard its call. The rarer the frog, the less likely it was you’d hear one.

Now, there are better tools for that.

The researcher-turned-entrepreneur reflects on his journey to co-founder of Surface Design Solutions